Envista Holdings Corporation
NVST Healthcare Medical Instruments & Supplies
Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024. In the quarter to June 2026, revenue grew 7.10%, EPS grew 106.3%, free cash flow grew 37.6% and total debt was flat, each against the same quarter a year earlier.
Follow NVST
Envista Holdings Corporation (NVST) EV/Sales
As of 16 October 2026, Envista Holdings Corporation (NVST) trades at a EV/Sales of 1.4×. Over the past ten years it has ranged from 0.0× (September 2019) to 4.1× (May 2021); the current reading is higher than 13% of that period. That is below the Medical Instruments & Supplies industry median of 2.9× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.5× | 1.26% |
| FY2024 | 1.5× | (18.88%) |
| FY2023 | 1.8× | (27.05%) |
| FY2022 | 2.5× | (17.96%) |
| FY2021 | 3.0× | (8.23%) |
| FY2020 | 3.3× | 44.61% |
| FY2019 | 2.3× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.6× | (0.37%) |
| Mar 2026 | 1.6× | 12.11% |
| Dec 2025 | 1.5× | 1.19% |
| Sep 2025 | 1.5× | (1.12%) |
| 27 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| NVST Envista Holdings Corporation | 1.4× |
| BLCO Bausch + Lomb Corporation compare | 2.0× |
| ICUI ICU Medical, Inc. compare | 2.3× |
| WRBY Warby Parker Inc. compare | 2.9× |
| MMSI Merit Medical Systems, Inc. compare | 3.6× |
| TFX Teleflex Incorporated compare | 3.6× |
| STVN Stevanato Group S.p.A. compare | 3.9× |
| ATRC AtriCure, Inc. compare | 4.7× |
| PLSE Pulse Biosciences, Inc compare | 2,555× |
| Medical Instruments & Supplies industry median | 2.9× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)